The early weeks of January are a wonderful time to reshuffle your stock portfolio and buy great stocks with big long-term upside. The bull case remains firmly in place even after the stock market's best back-to-back years since the late 1990s.
The article from MSN Money discusses two stocks, Pfizer (PFE) and Chevron (CVX), which are currently considered undervalued and good investment opportunities. Pfizer, despite a significant drop in its stock price due to lower demand for its COVID-19 products, is highlighted for its robust pipeline of new drugs and a promising cancer treatment, which could drive future growth. The company's low price-to-earnings ratio and a high dividend yield make it particularly attractive. Chevron, on the other hand, has seen its stock price decrease due to falling oil prices but remains a strong buy due to its solid financial health, with a low debt-to-equity ratio, and its commitment to increasing dividends and share repurchases. The article suggests that both companies are poised for recovery and growth, offering investors a chance to buy at a discount.
Business & Finance
